FIBRINOGENOPENIA AND FIBRINOLYSIS IN ACUTE MYELOGENOUS LEUKEMIA
Authors: A A COOPERBERG, G M NEIMAN
Journal: Annals of Internal Medicine (1955)

Case Reports1 March 1955FIBRINOGENOPENIA AND FIBRINOLYSIS IN ACUTE MYELOGENOUS LEUKEMIAARTHUR A. COOPERBERG, M.D., GREGORY M. A. NEIMAN, M.D.ARTHUR A. COOPERBERG, M.D.Search for more papers by this author, GREGORY M. A. NEIMAN, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-42-3-706 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptFibrinogenopenia in leukemia is a rare occurrence, according to the literature. Risak8 reported a marked fibrinogenopenia in three patients with acute myelogenous leukemia who died of severe bleeding. He assumed an impaired production of fibrinogen as the cause of the fibrinogenopenia, but tests for fibrinolysis were not carried out in these cases.In the case reported below a reduction in plasma fibrinogen was discovered in the course of examination of the blood. Further studies revealed the presence of a fibrinolysin, which was believed to be the cause of the fibrinogenopenia. In recent years the appearance of a fibrinolysin and fibrinogenopenia...Bibliography1. LewisFerguson JHJH: Studies on a proteolytic enzyme system in the blood. IV. Activation of profibrinolysin by serum fibrinolysokinase, Proc. Soc. Exper. Biol. and Med. 78: 184, 1951. CrossrefMedlineGoogle Scholar2. Lewis JH: Blood clotting and allied problems, Transactions of the Fifth Conference, 1952, Josiah Macy, Jr. Foundation, New York, p. 302. Google Scholar3. MacfarlaneBiggs RGR: Fibrinolysis. Its mechanism and significance, Blood 3: 1167, 1948. CrossrefMedlineGoogle Scholar4. MoloneyEganGorman WCWJAJ: Acquired afibrinogenemia in pregnancy, New England J. Med. 240: 596, 1949. CrossrefMedlineGoogle Scholar5. Proceedings of the Second Conference on Folic Acid Antagonists in the Treatment of Leukemia, Blood 7: 152-159, 1952. Google Scholar6. ReidWeinerRoby DEAECC: Intravascular clotting and afibrinogenemia, the presumptive lethal factors in the syndrome of amniotic fluid embolism, Am. J. Obst. and Gynec. 66: 465, 1953. CrossrefMedlineGoogle Scholar7. ReidWeinerRobyDiamond DEAECCLK: Maternal afibrinogenemia associated with long-standing intrauterine fetal death, Am. J. Obst. and Gynec. 66: 500, 1953. CrossrefMedlineGoogle Scholar8. Risak E: Die Fibrinopenie, Ztschr. f. klin. Med. 128: 605, 1935. Google Scholar9. SoulierMatheyLeBollockDaumetFayet JPJAGPH: Syndromes hemorragiques mortels avec incoagulabilite totale par defibrination et avec fibrinolyse, Rev. d'hémat. 7: 30, 1952. MedlineGoogle Scholar10. Stefanini M: Fibrinolysis and "fibrinolytic purpura," Blood 7: 1044, 1952. CrossrefMedlineGoogle Scholar11. TagnonWhitmoreShulman HJWFNR: Fibrinolysis in metastatic cancer of the prostate, Cancer 5: 9, 1952. CrossrefMedlineGoogle Scholar12. TagnonLevensonDavidsonTaylor HJSMCSFH: The occurrence of fibrinolysis in shock, with observations on the prothrombin time and the plasma fibrinogen during hemorrhagic shock, Am. J. M. Sc. 211: 88, 1946. CrossrefMedlineGoogle Scholar13. TagnonShulmanWhitmoreLeone HJPWFLA: Prostatic fibrinolysin, Am. J. Med. 15: 875, 1953. CrossrefMedlineGoogle Scholar14. WeinerReidRoby AEDECC: Incoagulable blood in severe premature separation of the placenta: a method of management, Am. J. Obst. and Gynec. 66: 475, 1953. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Montreal,*Received for publication April 30, 1954.From the Department of Medicine and Hematology Laboratory, Jewish General Hospital, Montreal, Canada. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAcute Promyelocytic Leukemia: Update on Risk Stratification and Treatment PracticesEarly mortality in acute promyelocytic leukemia: Potential predictors (Review)Acute promyelocytic leukemia: where did we start, where are we now, and the futureMyeloid leukaemic cells can lyse fibrin directlyMyeloid leukaemic cells can lyse fibrin directlyTHROMBOSIS AND HEMORRHAGE IN ONCOLOGY PATIENTSWhat's New in the Causes of Hemorrhage in Acute Myelogenous Leukemia?The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrinationBleeding Due to Thrombocytopenia in Acute Leukemias and Reevaluation of the Prophylactic Platelet Transfusion PolicyDie Hämostasestörung der akuten LeukämieThe Prophylactic Treatment of Thrombocytopenic Leukemic Patients with Platelets: a Double Blind StudyBLEEDING AND INTRAVASCULAR CLOTTING IN MALIGNANCY: A REVIEWNeubildungen des myeloischen SystemsDisorders of FibrinolysisCLINICAL EXPERIENCE WITH DETERMINATION OF FIBRINOGEN DEGRADATION PRODUCTSPhysiology and Biochemistry of FibrinolysisDisseminated intravascular coagulation—a complication of chemotherapy in acute myelomonocytic leukemiaCoagulation disorders in cancer. III.Fibrinolysis and inhibitorsFibrinolysis in leukaemiaHYPOFIBRINOGENAEMIA IN ACUTE LEUKAEMIA WITH EXTENSIVE FIBRINOUS PERICARDITISA Coagulation Study in Patients with NeuroblastomaFibrinolysis: An Unusual Cause of BleedingHYPOFIBRINOGENÆMIA WITHOUT INCREASED FIBRINOLYSIS IN LEUKÆMIAEffect of platelet transfusion on hemorrhage in patients with acute leukemia: An autopsy studyUngewöhnlicher Verlauf einer PromyelocytenleukämieReferencesInfluence of Blood Platelets on Fibrinolysis in Acute and Chronic Leukemia.Hypofibrinogenemic Hemorrhage in Acute Myelogenous Leukemia Treated with Heparin With Autopsy Findings of Widespread Intravascular ClottingWILLIAM G. BAKER, M.D., NILS U. BANG, M.D., RALPH L. NACHMAN, M.D., FARRO RAAFAT, M.D., HERBERT I. HOROWITZ, M.D.HEMORRHAGE IN SURGERY IN MYELOFIBROSIS, MULTIPLE MYELOMA, LEUKEMIA, AND LYMPHOMAS*ON-LINE DIGITAL COMPUTER USED IN BIOLOGICAL EXPERIMENTS AND MODELINGHypofibrinogenemia in Rocky Mountain Spotted FeverAcute Leukaemia in Pregnancy associated with HypofibrinogenaemiaSymptomatische Afibrinogen�mieEvaluation of Therapy with Fibrinolytic AgentsThe Quantitative Relation between Platelet Count and Hemorrhage in Patients with Acute LeukemiaClinical manifestations of leukemiaThe antiplasmin effect of plasma fractionsCIRCULATING FIBRINOLYSIN IN A CASE OF PROSTATIC CARCINOMA WITH BONY METASTASES*STANLEY BERGEN JR., M.D., FRED J. SCHILLING, M.D., F.A.C.P.Zur Blutgerinnung bei LeukosenHYPOFIBRINOGENEMIA WITHOUT FIBRINOLYSIS ASSOCIATED WITH A LYMPHOMA AND CONTROLLED AFTER TREATMENT WITH CORTISONE AND NITROGEN MUSTARD*JOHN E. MIDDLEBROOK, M.D.Bleeding Diathesis Associated with a Circulating Fibrinolysin: Report of Three CasesAUTOERYTHROCYTE SENSITIZATION WITH A CIRCULATING FIBRINOLYTIC FACTOR 1 March 1955Volume 42, Issue 3Page: 706-711KeywordsAcute myeloid leukemiaBlood plasmaFibrinogenFibrinolysisHematology and oncologyHemorrhageHospital medicineResearch laboratories ePublished: 1 December 2008 Issue Published: 1 March 1955 PDF downloadLoading ...